This reference view applies Relative Strength Index to Telix Pharmaceuticals Limited's historical closing prices. Telix Pharmaceuticals Limited's Relative Strength Index reference page summarizes the forecasted price and model accuracy metrics from daily trading data. Telix Pharmaceuticals Limited's forecast reference data is generated from the equity's historical trading prices. Mean absolute deviation and related metrics help quantify forecast uncertainty for Telix Pharmaceuticals Limited.
All forecast values on this page for Telix Pharmaceuticals Limited are Relative Strength Index reference data derived from historical price series.
Relative Strength Index Analysis Today
Telix Pharmaceuticals Limited has current Relative Strength Index of 61.08.
On March 27 2026 Telix Pharmaceuticals Limited was traded for 8.96 at the closing time. Highest Telix Pharmaceuticals's price during the trading hours was 8.96 and the lowest price during the day was 8.96 . There was no trading activity during the period. Lack of trading volume on the 27th of March did not result in any price rise and fall. The trading price change to current price is 0.11% .
Other Forecasting Options for Telix Pharmaceuticals
Volume-weighted price analysis for Telix Stock gives heavier weight to price levels where trading activity was highest. Crossovers in the MACD line and signal line can identify shifts in Telix momentum before they appear in raw price. Comparing Telix Pharmaceuticals' realized volatility to implied volatility reveals whether the options market expects larger or smaller moves. Readings above 80 or below 20 highlight potential reversal zones in Telix Stock price action.
Checking Telix Pharmaceuticals against related firms within the Health Care space helps investors see where the stock stands among peers. Market cap and total value checks frame Telix Pharmaceuticals' size within the competitive field. A stock that beats its peers on many metrics often deserves a closer look from value-focused investors.
Evaluating the market strength of Telix Pharmaceuticals stock allows investors to gauge shifts in market momentum. Monitoring these indicators highlights periods where Telix Pharmaceuticals Limited trading conditions shift meaningfully. These metrics are particularly useful when Telix Pharmaceuticals stock shows divergence from broader market trends. Regularly reviewing Telix Pharmaceuticals Limited strength signals helps maintain a structured approach to position management.
Understanding Telix Pharmaceuticals' risk indicators is essential for any investor seeking to forecast its future price accurately. By identifying how much risk is embedded in Telix Pharmaceuticals' investment, investors can decide how to position their exposure. Reviewing Telix Pharmaceuticals' basic risk indicators is essential for managing investment risk effectively. The risk-return trade-off for telix stock becomes clearer when Telix Pharmaceuticals' risk indicators are properly assessed.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Telix Pharmaceuticals
The amount of media and story coverage tied to Telix Pharmaceuticals Limited can signal where market attention is concentrating at the moment. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Short sentiment tied to Telix Pharmaceuticals Limited matters because heavier bearish pressure can change how quickly future price expectations become unstable. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
Common Stock Shares Outstanding
337.9 M
Cash And Short Term Investments
212.5 M
More Resources for Telix Stock Analysis
A structured review of Telix Pharmaceuticals begins with its financial statements and overall trends. Key reports that frame Telix Pharmaceuticals Limited Stock are listed below:
